Media Room
latest news

Report shows life sciences industry alliance is taking action to curb antimicrobial resistance, with more to come
The new AMR Industry Alliance of more than 100 biotech, diagnostics, generics and research-based biopharmaceutical companies and trade associations launches its first progress report today. The re...
Read more
New Alliance to Drive and Measure Industry Progress to Curb Antimicrobial Resistance
New Industry Alliance brings together research-based pharmaceutical companies, generics, biotech and diagnostic companies, to drive and measure industry progress to curb antimicrobial resistance....
Read more
AMR Roadmap Launched
Leading Pharmaceutical Companies Present Industry Roadmap to Combat Antimicrobial Resistance Comprehensive roadmap lays out key commitments the pharmaceutical companies pledge to deliver by 2020...
Read morefrom the blog

Accelerating the development and delivery of new innovations for a TB-free world
Before the World Economic Forum, Davos’ first claim to fame was as a haven for wealthy tuberculosis sufferers in the 1800s and 1900s: the rarefied air of the Magic Mountain, as Thomas Mann dubbed it...
Read more
A Frightening Reality
From a sustainable antibiotics perspective, 2018 is not wasting time getting to the point. The new year has kicked off with tremendous momentum in the fight against antimicrobial resistance (AMR), wit...
Read more
Antimicrobial resistance is a growing health challenge
This blog was first published on NJToday on 5 February 2018. The growing global public health challenge of Antimicrobial Resistance (AMR) cannot be understated. By 2050, it is a predicted to acco...
Read morein the press

Antimicrobial resistance and vaccines – Life science industry makes the link and drives progress
This Q&A was first published on PharmExec on 20 April, 2018. Interview by Julian Upton. 1. When trying to reduce antimicrobial resistance, how can vaccines help? Vaccines are critical and po...
Read more
NZZ – We need a sustainable business model
This interview was first published on NZZ on 24 February 2018. Interview by Birgit Voigt. NZZ on Sunday: Why is the pharmaceutical industry not developing more new antibiotics? Thomas Cueni: Today...
Read more
CGTN – Augmentation de la résistance antimicrobienne dans le monde
Garance Upham (Vice-President of World Against Antibiotic Resistance - WAAAR), Marc Sprenger Director WHO secretariat for antimicrobial resistance), Thomas Cueni (Chair of AMR Industry Alliance) expla...
Read more